GO
Loading...

'Poison Pill' inventor targets activism

Friday, 28 Mar 2014 | 7:34 AM ET

Activism in the long-term is not only bad for shareholders but also bad for the economy as a whole, says Martin Lipton, Wachtell, Lipton, Rosen & Katz, expressing his views on shareholder activism. Also Lipton shares his thoughts on the two categories of hedge fund activism.